Skip to main content

Medium-Throughput Production of Recombinant Human Proteins: Ligation-Independent Cloning

  • Protocol
  • First Online:

Part of the book series: Methods in Molecular Biology ((MIMB,volume 1091))

Abstract

Structural genomics groups have identified the need to generate multiple truncated versions of each target to improve their success in producing a well-expressed, soluble, and stable protein and one that crystallizes and diffracts to a sufficient resolution for structural determination. At the SGC, we opted for the Ligation-Independent Cloning (LIC) method which provides the medium throughput we desire to produce and screen many proteins in a parallel process. Here, we describe our LIC protocol for generating constructs in a 96-well format and provide a choice of vectors suitable for expressing proteins in both E. coli and the baculovirus expression vector system (BEVS).

This is a preview of subscription content, log in via an institution.

Buying options

Protocol
USD   49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   139.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Springer Nature is developing a new tool to find and evaluate Protocols. Learn more

References

  1. Abdellah Z, Ahmadi A, Ahmed S et al (2004) Finishing the euchromatic sequence of the human genome. Nature 431:931–945

    Article  Google Scholar 

  2. Haun RS, Serventi IM, Moss J (1992) Rapid, reliable ligation-independent cloning of PCR products using modified plasmid vectors. Biotechniques 13:515–518

    CAS  PubMed  Google Scholar 

  3. Hartley JL, Temple GF, Brasch MA (2000) DNA cloning using in vitro site-specific recombination. Genome Res 10:1788–1795

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Invitrogen (2010) Gateway® Technology: a universal technology to clone DNA sequences for functional analysis and expression in multiple systems. Invitrogen Life Technologies, Carlsbad

    Google Scholar 

  5. Walhout AJ, Temple GF, Brasch MA et al (2000) GATEWAY recombinational cloning: application to the cloning of large numbers of open reading frames or ORFeomes. Methods Enzymol 328:575–592

    Article  CAS  PubMed  Google Scholar 

  6. Li MZ, Elledge SJ (2005) MAGIC, an in vivo genetic method for the rapid construction of recombinant DNA molecules. Nat Genet 37:311–319

    Article  CAS  PubMed  Google Scholar 

  7. Clontech (2012) In-Fusion® HD cloning kit user manual. Clontech, Mountain View

    Google Scholar 

  8. Li MZ, Elledge SJ (2007) Harnessing homologous recombination in vitro to generate recombinant DNA via SLIC. Nat Methods 4:251–256

    Article  CAS  PubMed  Google Scholar 

  9. Li MZ, Elledge SJ (2012) SLIC: a method for sequence- and ligation-independent cloning. Methods Mol Biol 852:51–59

    Article  CAS  PubMed  Google Scholar 

  10. Hanahan D, Jessee J, Bloom FR et al (1991) Plasmid transformation of Escherichia coli and other bacteria. Methods Enzymol 204:63–113

    Article  CAS  PubMed  Google Scholar 

  11. Graslund S, Sagemark J, Berglund H et al (2008) The use of systematic N- and C-terminal deletions to promote production and structural studies of recombinant proteins. Protein Expr Purif 58:210–221

    Article  PubMed  Google Scholar 

  12. Bray JE (2012) Target selection for structural genomics based on combining fold recognition and crystallisation prediction methods: application to the human proteome. J Struct Funct Genomics 13:37–46

    Article  CAS  PubMed  Google Scholar 

  13. Savitsky P, Bray J, Cooper CD et al (2010) High-throughput production of human proteins for crystallization: the SGC experience. J Struct Biol 172:3–13

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We would like to thank all the SGC scientists (past and present) who contributed towards the development of the method. The SGC is a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, Genome Canada, GlaxoSmithKline, Lilly Canada, the Novartis Research Foundation, Pfizer, Takeda, AbbVie, the Canada Foundation for Innovation, the Ontario Ministry of Economic Development and Innovation, and the Wellcome Trust.

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media, LLC

About this protocol

Cite this protocol

Strain-Damerell, C., Mahajan, P., Gileadi, O., Burgess-Brown, N.A. (2014). Medium-Throughput Production of Recombinant Human Proteins: Ligation-Independent Cloning. In: Chen, Y. (eds) Structural Genomics. Methods in Molecular Biology, vol 1091. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-691-7_4

Download citation

  • DOI: https://doi.org/10.1007/978-1-62703-691-7_4

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-62703-690-0

  • Online ISBN: 978-1-62703-691-7

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics